Corteva (NYSE:CTVA) Price Target Raised to $95.00

Corteva (NYSE:CTVA) had its target price upped by Jefferies Financial Group from $85.00 to $95.00 in a research note released on Monday,MarketScreener reports. Jefferies Financial Group currently has a buy rating on the stock.

CTVA has been the topic of a number of other research reports. Deutsche Bank Aktiengesellschaft raised their price target on Corteva from $85.00 to $90.00 and gave the stock a “buy” rating in a report on Thursday, February 5th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Corteva in a research note on Monday, December 29th. Rothschild & Co Redburn cut their price target on Corteva from $71.00 to $65.00 and set a “neutral” rating for the company in a research note on Tuesday, November 11th. CICC Research lifted their price objective on shares of Corteva from $70.00 to $80.00 and gave the company an “outperform” rating in a research report on Wednesday, February 11th. Finally, Argus upgraded shares of Corteva to a “strong-buy” rating in a research report on Friday, January 16th. One analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Corteva has an average rating of “Moderate Buy” and an average price target of $82.80.

Corteva Price Performance

CTVA stock opened at $77.98 on Monday. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07. The company has a market capitalization of $52.44 billion, a P/E ratio of 49.35, a PEG ratio of 2.70 and a beta of 0.72. The business has a 50 day simple moving average of $72.63 and a 200-day simple moving average of $68.97. Corteva has a twelve month low of $53.40 and a twelve month high of $80.90.

Corteva (NYSE:CTVA) last released its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, meeting the consensus estimate of $0.22. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The firm had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $4.23 billion. During the same quarter in the prior year, the firm earned $0.32 EPS. Corteva’s revenue for the quarter was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, equities analysts anticipate that Corteva will post 2.96 EPS for the current year.

Corteva Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Shareholders of record on Monday, March 2nd will be issued a $0.18 dividend. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s dividend payout ratio (DPR) is 45.57%.

Insider Activity at Corteva

In related news, insider Brian Titus sold 8,311 shares of Corteva stock in a transaction on Friday, February 20th. The stock was sold at an average price of $76.55, for a total transaction of $636,207.05. Following the completion of the transaction, the insider directly owned 8,090 shares of the company’s stock, valued at approximately $619,289.50. The trade was a 50.67% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. 0.14% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in CTVA. Activest Wealth Management increased its holdings in Corteva by 118.3% during the 3rd quarter. Activest Wealth Management now owns 369 shares of the company’s stock valued at $25,000 after acquiring an additional 200 shares in the last quarter. JPL Wealth Management LLC acquired a new stake in shares of Corteva in the third quarter valued at approximately $25,000. True Wealth Design LLC increased its stake in shares of Corteva by 209.5% during the 3rd quarter. True Wealth Design LLC now owns 390 shares of the company’s stock worth $26,000 after purchasing an additional 264 shares in the last quarter. Total Investment Management Inc. acquired a new position in shares of Corteva during the 2nd quarter worth approximately $27,000. Finally, Garton & Associates Financial Advisors LLC purchased a new stake in Corteva in the 4th quarter valued at approximately $27,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.